
    
      Amendment was made, and approved by WIRB in January 2009, to this protocol: We propose a
      largely retrospective study with short-term prospective follow-up in a subgroup of patients
      who have not yet been treated with 96 weeks of entecavir following adefovir treatment. The
      aim of the study is to describe sequential virologic response to adefovir and entecavir.
    
  